BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9656818)

  • 21. Mixed medullary and follicular cell carcinoma of the thyroid with lymph node metastasis in a 7-year-old child.
    Goyal R; Nada R; Rao KL; Radotra BD
    Pathol Int; 2006 Feb; 56(2):84-8. PubMed ID: 16445820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Insullar cancer. Diagnosis and place in the structure of thyroid carcinoma].
    Pavlovskaia AI; Rotin DL; Savelov NA; Gurevich LE; Smirnova EA; Shishkov RV
    Arkh Patol; 2005; 67(6):16-8. PubMed ID: 16405014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Usefulness of the genetic study in the diagnosis of medullary carcinoma of the thyroid].
    Rafecas A; Ribas Y; Villabona C; Viladrich M; Figueras J; Fabregat J; Torras J; Gómez JM; Jaurrieta E
    Med Clin (Barc); 1998 Nov; 111(16):619-22. PubMed ID: 9881336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusual tumors of the thyroid gland.
    Baloch ZW; LiVolsi VA
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):297-310, vii. PubMed ID: 18502328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cribriform-morular variant of papillary carcinoma: the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma. A case report with clinical and molecular genetic correlation.
    Ng SB; Sittampalam K; Goh YH; Eu KW
    Pathology; 2003 Feb; 35(1):42-6. PubMed ID: 12701683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components.
    Volante M; Papotti M; Roth J; Saremaslani P; Speel EJ; Lloyd RV; Carney JA; Heitz PU; Bussolati G; Komminoth P
    Am J Pathol; 1999 Nov; 155(5):1499-509. PubMed ID: 10550306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma: Turkish experience.
    Erdogan MF; Gursoy A
    Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():503-7. PubMed ID: 17551473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Papillary and follicular thyroid carcinoma].
    Schlumberger M
    Ann Endocrinol (Paris); 2007 Jun; 68(2-3):120-8. PubMed ID: 17582381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of molecular abnormalities leading to thyroid carcinogenesis: a 1993 perspective.
    Gagel RF
    Stem Cells; 1997; 15 Suppl 2():7-13. PubMed ID: 9368282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid carcinoma: diagnostic and therapeutic approach; genetic background (review).
    Lewinski A; Ferenc T; Sporny S; Jarzab B
    Endocr Regul; 2000 Jun; 34(2):99-113. PubMed ID: 10991553
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thyroid gland carcinoma].
    Schmid KW
    Praxis (Bern 1994); 1998 Mar; 87(11):367-74. PubMed ID: 9562812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyalinizing trabecular tumor of the thyroid. An overcautious designation of a benign thyroid tumour?].
    Ting S; Puttinger C; Schmid KW; Sheu-Grabellus SY
    Pathologe; 2012 Mar; 33(2):135-41. PubMed ID: 21842215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xenotransplanted thyroid tumors heterogeneously express differentiation markers in nude rats.
    Hoang-Vu C; Scheumann GF; Dralle H; Schröder S; von zur Mühlen A; Brabant G
    Transplant Proc; 1993 Oct; 25(5):2799. PubMed ID: 8212238
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunoreactivity of nuclear protein p53 in differentiated thyroid cancers].
    Dedov II; Gerasimov GA; Bronshteĭn MI; Aleksandrova GF; Troshina EA; Figge J
    Biull Eksp Biol Med; 1996 Dec; 122(12):645-7. PubMed ID: 9280463
    [No Abstract]   [Full Text] [Related]  

  • 35. MET receptor tyrosine kinase sequence alterations in differentiated thyroid carcinoma.
    Wasenius VM; Hemmer S; Karjalainen-Lindsberg ML; Nupponen NN; Franssila K; Joensuu H
    Am J Surg Pathol; 2005 Apr; 29(4):544-9. PubMed ID: 15767811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial follicular cell tumors: classification and morphological characteristics.
    Nosé V
    Endocr Pathol; 2010 Dec; 21(4):219-26. PubMed ID: 20878367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of several novel non-p.R132 IDH1 variants in thyroid carcinomas.
    Hemerly JP; Bastos AU; Cerutti JM
    Eur J Endocrinol; 2010 Nov; 163(5):747-55. PubMed ID: 20702649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene Fusions in Thyroid Cancer.
    Yakushina VD; Lerner LV; Lavrov AV
    Thyroid; 2018 Feb; 28(2):158-167. PubMed ID: 29281951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunohistology and prognosis in thyroid cancer. Determination of the malignancy potential of papillary and medullary neoplasms by the detection of S-100 protein and Leu-M1 antigen].
    Schröder S; Dralle H; Bay V; Böcker W
    Acta Med Austriaca; 1989; 16(1):2-5. PubMed ID: 2711816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thyroid tumours with a long clinical course: diagnostic and therapeutic aspects (author's transl)].
    Rabenhorst G; Kriegel L
    Dtsch Med Wochenschr; 1975 Mar; 100(11):533-5. PubMed ID: 1116434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.